These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 28215640

  • 1. Immunohistochemical expression of galectin-3 is significantly associated with grade, stage and differentiation of endometrial carcinomas.
    Al-Maghrabi J, Abdelrahman AS, Ghabrah T, Butt NS, Al-Maghrabi B, Khabaz MN.
    Pathol Res Pract; 2017 Apr; 213(4):348-352. PubMed ID: 28215640
    [Abstract] [Full Text] [Related]

  • 2. Cyclin D1 is significantly associated with stage of tumor and predicts poor survival in endometrial carcinoma patients.
    Khabaz MN, Abdelrahman AS, Butt NS, Al-Maghrabi B, Al-Maghrabi J.
    Ann Diagn Pathol; 2017 Oct; 30():47-51. PubMed ID: 28965628
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype.
    Schlosshauer PW, Ellenson LH, Soslow RA.
    Mod Pathol; 2002 Oct; 15(10):1032-7. PubMed ID: 12379748
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Epidermal growth factor receptor expression in serous ovarian carcinoma: an immunohistochemical study with galectin-3 and cyclin D1 and outcome.
    Brustmann H.
    Int J Gynecol Pathol; 2008 Jul; 27(3):380-9. PubMed ID: 18580315
    [Abstract] [Full Text] [Related]

  • 12. Are the uterine serous carcinomas underdiagnosed? Histomorphologic and immunohistochemical correlates and clinical follow up in high-grade endometrial carcinomas initially diagnosed as high-grade endometrioid carcinoma.
    Hu S, Hinson JL, Matnani R, Cibull ML, Karabakhtsian RG.
    Mod Pathol; 2018 Feb; 31(2):358-364. PubMed ID: 28984301
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas.
    Wu W, Slomovitz BM, Celestino J, Chung L, Thornton A, Lu KH.
    Cancer Res; 2003 Oct 01; 63(19):6195-9. PubMed ID: 14559803
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis.
    Reid-Nicholson M, Iyengar P, Hummer AJ, Linkov I, Asher M, Soslow RA.
    Mod Pathol; 2006 Aug 01; 19(8):1091-100. PubMed ID: 16648864
    [Abstract] [Full Text] [Related]

  • 20. Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas.
    Siami K, McCluggage WG, Ordonez NG, Euscher ED, Malpica A, Sneige N, Silva EG, Deavers MT.
    Am J Surg Pathol; 2007 Nov 01; 31(11):1759-63. PubMed ID: 18059234
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.